These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 2554076)

  • 41. Clinical significance of simultaneous determinations of alpha-fetoprotein and des-gamma-carboxy prothrombin in monitoring recurrence in patients with hepatocellular carcinoma.
    Aoyagi Y; Oguro M; Yanagi M; Mita Y; Suda T; Suzuki Y; Hata K; Ichii K; Asakura H
    Cancer; 1996 May; 77(9):1781-6. PubMed ID: 8646674
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Detection of alpha-fetoproteins mRNA and melanoma antigen-1 mRNA in peripheral blood of patients with hepatocellular carcinoma and its clinical significance].
    Yang SZ; Dong JH; Zhu J; Li K; Zhang Y
    Zhonghua Wai Ke Za Zhi; 2004 Sep; 42(17):1060-3. PubMed ID: 15498320
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differential tumor markers and hepatitis markers profile in liver tumors.
    Khalifa A; Mady EA; Abadeer N; Kamal A
    Anticancer Res; 1999; 19(4A):2495-500. PubMed ID: 10470181
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of interleukin-6, interleukin-10 and human hepatocyte growth factor as tumor markers for hepatocellular carcinoma.
    Hsia CY; Huo TI; Chiang SY; Lu MF; Sun CL; Wu JC; Lee PC; Chi CW; Lui WY; Lee SD
    Eur J Surg Oncol; 2007 Mar; 33(2):208-12. PubMed ID: 17140760
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Significance of Golgi glycoprotein 73, a new tumor marker in diagnosis of hepatocellular carcinoma: a primary study].
    Mao YL; Yang HY; Xu HF; Sang XT; Lu X; Yang ZY; Zhang JC; Zhong SX; Huang JF; Zhang HB
    Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(14):948-51. PubMed ID: 18756964
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The humoral immune response to p53 in patients with hepatocellular carcinoma is specific for malignancy and independent of the alpha-fetoprotein status.
    Volkmann M; Müller M; Hofmann WJ; Meyer M; Hagelstein J; Räth U; Kommerell B; Zentgraf H; Galle PR
    Hepatology; 1993 Sep; 18(3):559-65. PubMed ID: 7689531
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Elevated serum chromogranin A in patients with hepatocellular carcinoma.
    Leone N; Pellicano R; Brunello F; Rizzetto M; Ponzetto A
    Clin Exp Med; 2002 Nov; 2(3):119-23. PubMed ID: 12447608
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Staging hepatocellular carcinoma by a novel scoring system (BALAD score) based on serum markers.
    Toyoda H; Kumada T; Osaki Y; Oka H; Urano F; Kudo M; Matsunaga T
    Clin Gastroenterol Hepatol; 2006 Dec; 4(12):1528-36. PubMed ID: 17162244
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Quantitative correlation of serum levels and tumor expression of vascular endothelial growth factor in patients with hepatocellular carcinoma.
    Poon RT; Lau CP; Cheung ST; Yu WC; Fan ST
    Cancer Res; 2003 Jun; 63(12):3121-6. PubMed ID: 12810638
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical significance of plasma D-dimer levels and serum VEGF levels in patients with hepatocellular carcinoma.
    Tseng CS; Lo HW; Chen PH; Chuang WL; Juan CC; Ker CG
    Hepatogastroenterology; 2004; 51(59):1454-8. PubMed ID: 15362775
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical course of chronic hepatitis C in patients with very high serum alpha-fetoprotein levels and normal hepatic imaging.
    Gonzalez SA; Jacobson IM
    Am J Gastroenterol; 2005 Apr; 100(4):977-8. PubMed ID: 15784045
    [No Abstract]   [Full Text] [Related]  

  • 52. Acarboxy prothrombin (PIVKA II) as a tumour marker for hepatocellular carcinoma and other liver diseases.
    Mohamedein A; Yousif-Kadaru AG; Ahmed SA; Saida H; Zaki ZA; Eldin ; Fedail SS
    East Afr Med J; 1995 Sep; 72(9):584-7. PubMed ID: 7498046
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of alpha-fetoprotein with some other tumour markers in Malaysians with hepatocellular carcinoma.
    Lopez JB; Balasegaram M; Timor J; Thambyrajah V
    Malays J Pathol; 1997 Jun; 19(1):53-8. PubMed ID: 10879242
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Patterns of and risk factors for recurrence after liver resection for well-differentiated hepatocellular carcinoma: a special reference to multicentric carcinogenesis after operation.
    Kubo S; Kinoshita H; Hirohashi K; Tanaka H; Tsukamoto T; Hamba H; Shuto T; Yamamoto T; Ikebe T; Wakasa K
    Hepatogastroenterology; 1999; 46(30):3212-5. PubMed ID: 10626188
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Prevalence and prognostic value of serum anti-p53 antibodies in hepatocellular carcinoma. A study of 159 patients].
    Sitruk V; Vaysse J; Chevret S; Ganne-Carrie N; Christidis C; Trinchet J; Beaugrand M
    Gastroenterol Clin Biol; 2000 Dec; 24(12):1159-63. PubMed ID: 11173728
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Are both PIVKA-II and alpha-fetoprotein necessary in follow-up management after hepatic resection for hepatocellular carcinoma?
    Koh T; Taniguchi H; Katoh H; Kunishima S; Yamaguchi A; Yamagishi H
    Hepatogastroenterology; 2002; 49(48):1615-8. PubMed ID: 12397748
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Serum 90K/MAC-2BP glycoprotein levels in hepatocellular carcinoma and cirrhosis.
    Correale M; Giannuzzi V; Iacovazzi PA; Valenza MA; Lanzillotta S; Abbate I; Quaranta M; Caruso ML; Elba S; Manghisi OG
    Anticancer Res; 1999; 19(4C):3469-72. PubMed ID: 10629637
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Serum inhibitors of streptolysin O in primary liver cancer].
    Baylet R; Yven J
    Bull Soc Med Afr Noire Lang Fr; 1968; 13(3):553-4. PubMed ID: 4306561
    [No Abstract]   [Full Text] [Related]  

  • 59. [Erythropoietin producing tumor].
    Takaku F
    Nihon Rinsho; 1971 Oct; 29(10):2234-41. PubMed ID: 4333959
    [No Abstract]   [Full Text] [Related]  

  • 60. [5'-nucleotide phosphodiesterase isozyme -V (5' -NPD-V)].
    Ikeda Y; Takami H
    Nihon Rinsho; 2010 Jul; 68 Suppl 7():765-7. PubMed ID: 20960868
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.